Insider Trading & Ownership of Praveen Tyle

Location
Rochester, NY
Summary
The estimated net worth of Praveen Tyle is at least $19,855 dollars as of 02 Apr 2025. Praveen Tyle is the Director of KIORA PHARMACEUTICALS INC and owns shares of KIORA PHARMACEUTICALS INC (KPRX) stock worth about $19.9K.
Signature
/s/ Melissa Tosca, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Praveen Tyle and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Praveen Tyle has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $19,855.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: KIORA PHARMACEUTICALS INC ($19,855).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Praveen Tyle

Insider Transactions Reported by Praveen Tyle:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .